1. Clinical & Scientific Overview
Amitriptyline Hydrochloride (TIP-MED-000211, Reference Code [11.7]) is classified under
CNS & Psychiatric Medicines (Ch 11) as a Tertiary-Amine Tricyclic Antidepressant (TCA; Serotonin & Norepinephrine Reuptake Inhibitor with Potent Antimuscarinic, Anti-H1 & Alpha-1 Blocking Activity).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 11 [11.7], p. 143): Tryptomer (MSD/Wockhardt), Sarotena (Lundbeck), Eliwel (Sun Pharma), Amitone (Intas), Amixide (with Chlordiazepoxide) — Strengths & Dosage Forms: Oral Film-Coated Tablets: 10 mg, 25 mg, 50 mg, 75 mg; Sustained-Release: 50 mg SR, 75 mg SR
Oral Film-Coated Tablets: 10 mg, 25 mg, 50 mg, 75 mg; Sustained-Release: 50 mg SR, 75 mg SR
3. Mechanism of Action & Pharmacodynamics
Tertiary-Amine Tricyclic Antidepressant (TCA; Serotonin & Norepinephrine Reuptake Inhibitor with Potent Antimuscarinic, Anti-H1 & Alpha-1 Blocking Activity) acting on target receptor/enzyme pathways in CNS & Psychiatric Medicines (Ch 11): clinical efficacy is mediated via Tertiary-Amine Tricyclic Antidepressant (TCA; Serotonin & Norepinephrine Reuptake Inhibitor with Potent Antimuscarinic, Anti-H1 & Alpha-1 Blocking Activity) for In contemporary Indian OPD practice, rarely used at high doses (75–150 mg) for depression; instead, very widely prescribed at Low Doses (10 mg to 25 mg at bedtime) for: (1) Migraine Prophylaxis and Chronic Tension-Type Headache, (2) Neuropathic Pain (Diabetic Neuropathy, Post-Herpetic Neuralgia, Sciatica), (3) Fibromyalgia, and (4) Irritable Bowel Syndrome (IBS-D) / Interstitial Cystitis..
4. Therapeutic Indications & Evidence-Supported Uses
- In contemporary Indian OPD practice, rarely used at high doses (75–150 mg) for depression
- instead, very widely prescribed at Low Doses (10 mg to 25 mg at bedtime) for: (1) Migraine Prophylaxis and Chronic Tension-Type Headache, (2) Neuropathic Pain (Diabetic Neuropathy, Post-Herpetic Neuralgia, Sciatica), (3) Fibromyalgia, and (4) Irritable Bowel Syndrome (IBS-D) / Interstitial Cystitis
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: Neuropathic Pain / Migraine Prophylaxis / Fibromyalgia: Initiate at 10 mg once daily (1–2 hours before bedtime); may titrate gradually if needed to 25 mg–50 mg at night. (Major Depression: 50–150 mg/day, largely replaced by SSRIs). Follow physician prescription.
Administration & Meal Timing: With or without food. | Take 1 to 2 hours BEFORE bedtime (e.g., 08:30–09:00 PM rather than 11:00 PM)! Taking amitriptyline 2 hours before sleep allows peak sedation to occur during sleep while ensuring the drug wears off by 07:00 AM, preventing severe morning 'hangover' drowsiness!
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: Excreted as glucuronide metabolites; start at 10 mg in CKD and monitor for sedation/urinary retention. Hepatic: Extensively metabolised by hepatic CYP2C19 and CYP2D6—reduce dose in liver disease and avoid in severe cirrhosis.
Renal: Excreted as glucuronide metabolites; start at 10 mg in CKD and monitor for sedation/urinary retention. Hepatic: Extensively metabolised by hepatic CYP2C19 and CYP2D6—reduce dose in liver disease and avoid in severe cirrhosis.
Renal: Excreted as glucuronide metabolites; start at 10 mg in CKD and monitor for sedation/urinary retention. Hepatic: Extensively metabolised by hepatic CYP2C19 and CYP2D6—reduce dose in liver disease and avoid in severe cirrhosis.
7. Contraindications, Precautions & High-Risk Warnings
- STRICTLY CONTRAINDICATED in Recent Myocardial Infarction, Cardiac Conduction Defects (Bundle Branch Block, 2nd/3rd Degree AV Block, QTc Prolongation, Arrhythmias), Narrow-Angle Glaucoma, Acute Urinary Retention / Severe Benign Prostatic Hyperplasia (BPH), and within 14 days of MAOIs! Narrow therapeutic index in overdose (cardiotoxic sodium-channel blockade).
Key Clinical Precautions: Renal: Excreted as glucuronide metabolites; start at 10 mg in CKD and monitor for sedation/urinary retention. Hepatic: Extensively metabolised by hepatic CYP2C19 and CYP2D6—reduce dose in liver disease and avoid in severe cirrhosis.
8. Adverse Effects Profile
- Potent Anticholinergic, Anti-H1 & Alpha-1 Side Effects (even at 10–25 mg in the elderly!): Severe dry mouth (xerostomia), daytime drowsiness/sedation, constipation, blurred vision (loss of near accommodation), urinary hesitancy, resting sinus tachycardia, orthostatic hypotension (dizziness upon standing), and weight gain.
- Acute Urinary Retention in elderly men with BPH, Acute Angle-Closure Glaucoma crisis, Anticholinergic Delirium, Confusion, Memory Loss, and Dementia progression in the elderly, Orthostatic Syncope & Hip-Fracture Falls, QTc Prolongation, Torsades de Pointes, and Complete Heart Block, paralytic ileus.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- CYP2D6 Inhibitors (Fluoxetine, Paroxetine, Bupropion, Terbinafine, Quinidine, Cimetidine): Block hepatic metabolism of Amitriptyline and its active metabolite Nortriptyline—increasing plasma TCA levels 2- to 4-fold and precipitating fatal cardiac arrhythmias and delirium! 2
- Anticholinergic Drugs (Tiotropium, Ipratropium, Solifenacin, Oxybutynin, Trihexyphenidyl, CPM/Atarax): Severe additive anticholinergic load (delirium, urinary retention, faecal impaction)
- QTc-Prolonging Drugs (Amiodarone, Sotalol, Domperidone, Ondansetron, Fluoroquinolones, Macrolides): Ventricular arrhythmias
- Tramadol & SSRIs: Serotonin syndrome and seizure threshold lowering
- Clonidine: Amitriptyline blocks the central alpha-2 antihypertensive action of clonidine!
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: 1. Explain that Tryptomer 10 mg is prescribed to quiet down sensitive pain/migraine pathways in the nervous system, not because the doctor thinks the pain is 'imaginary or psychiatric'. 2. Take at 8:30 PM (2 hours before bed) to avoid waking up groggy the next morning. 3. Rise slowly from bed at night. Men with prostate enlargement must stop the tablet and report immediately if passing urine becomes difficult.
- Meal & Clock Timing Instruction: With or without food. (Take 1 to 2 hours BEFORE bedtime (e.g., 08:30–09:00 PM rather than 11:00 PM)! Taking amitriptyline 2 hours before sleep allows peak sedation to occur during sleep while ensuring the drug wears off by 07:00 AM, preventing severe morning 'hangover' drowsiness!)
- Missed Dose Protocol: If forgotten at night, SKIP the missed dose the next morning (taking amitriptyline in the morning causes severe all-day drowsiness!); resume the next evening at 8:30 PM.
- Geriatric Dispensing Pearl: Beers Criteria Top-Priority Drug to Avoid in the Elderly (Anticholinergic Burden Score = 3, the maximum score!): Amitriptyline has the highest anticholinergic, sedating, and orthostatic toxicity of all TCAs. In elderly CGHS patients with neuropathic pain, strongly advise the physician to consider low-dose Pregabalin/Gabapentin or Duloxetine (or if a tricyclic is strictly needed, secondary-amine Nortriptyline 10 mg has ~50% less alpha-1 orthostasis and anticholinergic toxicity than Amitriptyline, though still requires caution!).
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets: 10 mg, 25 mg, 50 mg, 75 mg; Sustained-Release: 50 mg SR, 75 mg SR
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 11 [11.7] (p. 143)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [11.19]-CMP139 Fluvoxamine Maleate IP — Selective Serotonin Reuptake Inhibitor (SSRI with Mild Anticholin
- [11.21]-CMP140 Bupropion Hydrochloride SR/XL IP — Noradrenergic and Specific Serotonergic Antidepressant (NaSSA; Ce
- [11.22]-CMP141 Trihexyphenidyl (Benzhexol) Hydrochloride IP — First-Generation (Typical) Butyrophenone Antipsychotic (Potent Do
- [11.23]-CMP142 Olanzapine IP & Risperidone IP — Second-Generation (Atypical) Dibenzothiazepine Antipsychotic & Mo
